|
Catalog# |
BRP1191-1 |
|---|---|
|
Lot # |
Check on the product label |
|
Size |
10 μg |
|
Description |
Recombinant mouse IL-1a is produced by the E.coli system, with the target gene encoding Ser115-Ser270 expressed. |
|
Synonyms |
IL1A, IL-1A, IL1, IL1-ALPHA, IL1F1, interleukin 1 alpha, IL-1 alpha, IL-1α |
|
Source |
E.coli |
|
Uniprot No. |
P01583 |
|
Purity |
>95% by SDS-PAGE |
|
Endotoxin level |
<1 EU/µg by LAL test |
|
Formulation |
Lyophilized from a 0.2 μm filtered solution of 20mM Tris-HCl, 6%Sucrose, 2%Mannitol, 50mM Arginine, 0.03% Tween80, pH 8.0. |
|
Reconstitution |
Dissolve the lyophilized protein in distilled water (It is not recommended to reconstitute to a concentration <100 μg/ml.) |
|
Application |
SDS-PAGE Other applications have not been tested. The optimal dilutions should be determined by end user. |
|
Storage& Expiration |
Ship at 4℃. Upon receipt, aliquot and store at -20℃ or -80℃ for long term. Avoid repeated freeze and thaw cycles. |
|
Background |
Interleukin-1 alpha (IL-1 alpha) also known as hematopoietin 1 is a cytokine of the interleukin 1 family that in humans is encoded by the IL1A gene. In general, Interleukin 1 is responsible for the production of inflammation, as well as the promotion of fever and sepsis. IL-1α inhibitors are being developed to interrupt those processes and treat diseases. IL-1α is produced mainly by activated macrophages, as well as neutrophils, epithelial cells, and endothelial cells. It possesses metabolic, physiological, haematopoietic activities, and plays one of the central roles in the regulation of the immune responses. It binds to the interleukin-1 receptor. It is on the pathway that activates tumor necrosis factor-alpha. |
|
Reference |
1. Nicklin MJ, Weith A, Duff GW (Jan 1994). "A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes". Genomics. 19 (2): 382–4. 2. March CJ, Mosley B, Larsen A, Cerretti DP, Braedt G, Price V, et al. (August 1985). "Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs". Nature. 315 (6021): 641–7. |

